All lobbying filings

KELLEY DRYE & WARREN LLP

Lobbying for LABORATORY CORPORATION OF AMERICA HOLDINGS · Clinical laboratory

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · North Carolina · House · Senate · $110,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 3

HR 5269
RESULTS Act
S 2761
RESULTS Act
HR 7148
Consolidated Appropriations Act, 2026

Lobbying activity 1

Health Issues

Healthcare issues relating to clinical laboratories; H.R. 5269/S. 2761,the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, and Section 6226 of H.R. 7148, the Consolidated Appropriations Act, 2026, Pub. L. 119-75, provisions relating to reform of Medicare reimbursement for clinical laboratory services under Section 216 of the Protecting Access to Medicare Act, Pub. L. 113-93; Federal policy relating to oversight of laboratory-developed tests; and Federal policy relating to supply chain issues affecting pre-clinical biomedical research for drug development.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.